Xia Chu

State Key Laboratory Of Chemo And Biosensing
Changsha, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Semi-Synthetic LC3-Interacting Degrader for Visualizing Macroautophagic Activity and Targeted Degradation.

Semi-Synthetic LC3-Interacting Degrader for Visualizing Macroautophagic Activity and Targeted Degradation.

Journal: Angewandte Chemie (International ed. in English)

Published: June 16, 2026

Programmable Chimeric Antigen Receptor T Cell Circuits With DNA Computing for Precision Tumor Therapy.

Programmable Chimeric Antigen Receptor T Cell Circuits With DNA Computing for Precision Tumor Therapy.

Journal: Angewandte Chemie (International ed. in English)

Published: January 08, 2026

Sensing and Reprogramming Surface Receptor Activation With Synthetic Transcriptional Circuits.

Sensing and Reprogramming Surface Receptor Activation With Synthetic Transcriptional Circuits.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 07, 2025

Single-walled carbon nanotubes hitchhike on Ly-6Chi monocytes for photoacoustic image-guided photothermal shock therapy of metabolic inflammation.

Single-walled carbon nanotubes hitchhike on Ly-6Chi monocytes for photoacoustic image-guided photothermal shock therapy of metabolic inflammation.

Journal: Chemical science

Published: July 09, 2025

Harnessing Nanomaterials for Enhanced DNA-Based Biosensing and Therapeutic Performance.

Harnessing Nanomaterials for Enhanced DNA-Based Biosensing and Therapeutic Performance.

Journal: Chembiochem : a European journal of chemical biology

Published: November 16, 2024

Surgical tumor-derived nanoplatform targets tumor-associated macrophage for personalized postsurgical cancer immunotherapy.

Surgical tumor-derived nanoplatform targets tumor-associated macrophage for personalized postsurgical cancer immunotherapy.

Journal: Science advances

Published: March 27, 2024

DNA nanodevice as a multi-module co-delivery platform for combination cancer immunotherapy.

DNA nanodevice as a multi-module co-delivery platform for combination cancer immunotherapy.

Journal: Journal of colloid and interface science

Published: February 21, 2024

G-Quadruplex RNA Based PROTAC Enables Targeted Degradation of RNA Binding Protein FMRP for Tumor Immunotherapy.

G-Quadruplex RNA Based PROTAC Enables Targeted Degradation of RNA Binding Protein FMRP for Tumor Immunotherapy.

Journal: Angewandte Chemie (International ed. in English)

Published: February 09, 2024

A nano-bioconjugate modified with anti-SIRPα antibodies and antisense oligonucleotides of mTOR for anti-atherosclerosis therapy.

A nano-bioconjugate modified with anti-SIRPα antibodies and antisense oligonucleotides of mTOR for anti-atherosclerosis therapy.

Journal: Acta biomaterialia

Published: October 28, 2023

A DNA Logic Circuit Equipped with a Biological Amplifier Loaded into Biomimetic ZIF-8 Nanoparticles Enables Accurate Identification of Specific Cancers In Vivo.

A DNA Logic Circuit Equipped with a Biological Amplifier Loaded into Biomimetic ZIF-8 Nanoparticles Enables Accurate Identification of Specific Cancers In Vivo.

Journal: Angewandte Chemie (International ed. in English)

Published: May 18, 2023

Neutrophil-Membrane-Coated Biomineralized Metal-Organic Framework Nanoparticles for Atherosclerosis Treatment by Targeting Gene Silencing.

Neutrophil-Membrane-Coated Biomineralized Metal-Organic Framework Nanoparticles for Atherosclerosis Treatment by Targeting Gene Silencing.

Journal: ACS nano

Published: April 06, 2023

Type I Photosensitizer Targeting G-Quadruplex RNA Elicits Augmented Immunity for Cancer Ablation.

Type I Photosensitizer Targeting G-Quadruplex RNA Elicits Augmented Immunity for Cancer Ablation.

Journal: Angewandte Chemie (International ed. in English)

Published: January 04, 2023

Showing 1-12 of 61

Last Updated: 09/26/2026